Evidence map›Paper›PMID 15949649›Full record

ArticleSchizophrenia research2005

Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression.

Jose Javier Miguel-Hidalgo, Priti Dubey, Qingmei Shao, Craig Stockmeier, Grazyna Rajkowska

Abstract read
In one paragraph

Article in Schizophrenia research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Biological substrates underpinning diagnosis of major depression.The international journal of neuropsychopharmacology · 2013
    Review
  6. Article
  7. Review
  8. Article
  9. Sex-specific programming of offspring emotionality after stress early in pregnancy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008
    Article
  10. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jose Javier Miguel-HidalgoDepartment of Psychiatry, University of Mississippi Medical Center, 2500 North State Street, P.O. Box 127, Jackson, MS 39216, USA. jmiguel-hidalgo@psychiatry.umsmed.edu
Priti Dubey
Qingmei Shao
Craig Stockmeier
Grazyna Rajkowska
University of Mississippi Medical Center · USState Street (United States) · US

Funding

Recruitment and Assessment Core Patient RecruitmentP50MH060451 · NIMH · DUKE UNIVERSITY · PI MCCARTHY, GREGORY E · 2001 to 2010
$22.3M
VOLTAGE-GATED CA CHANNELS &NMDA RECEPTOR SUBUNITS IN LC OF ALCOHOLICSP20RR017701 · NCRR · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI PAUL, IAN A. · 2002 to 2011
$20.2M
Limbic Dopaminergic System in Major DepressionR01MH063187 · NIMH · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI ORDWAY, GREGORY ALLEN · 2002 to 2005
$1.5M
Prefrontal Cell Pathology Distinguishes Mental DisordersR01MH061578 · NIMH · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI RAJKOWSKA, GRAZYNA · 2001 to 2003
$632k
NCRR NIH HHS P20 RR017701NIMH NIH HHS MH60451NIMH NIH HHS MH61578NIMH NIH HHS MH63187NIMH NIH HHS P50 MH060451NIMH NIH HHS R01 MH061578NIMH NIH HHS R01 MH063187
6 · The paper itself

Abstract

Morphometric changes in the general population of Nissl-stained neurons in area 9 of the dorsolateral prefrontal cortex have been reported in major depressive disorder (MDD) and schizophrenia. These alterations include lamina-specific reductions in the packing density of neuronal somata in MDD, increases or reductions in the density of neuronal somata in schizophrenia, and reductions in average size of neuronal somata in both MDD and schizophrenia. These changes are prominent in deep layer III, where pyramidal excitatory neurons establishing cortico-cortical association connections are localized. To test whether deep layer III pyramidal neurons are differentially affected in MDD or schizophrenia, an antibody was used that labels both phosphorylated and non-phosphorylated forms of the 200 kD neurofilament protein (NF200) in pyramidal cells of layer III in area 9. The packing density and somal size of NF200-immunoreactive (IR) pyramidal neurons were measured in area 9 in 13 subjects with nonpsychotic MDD, 11 subjects with schizophrenia and 13 psychiatrically normal controls. Analysis of covariance did not reveal a difference in packing density among groups. However, the mean size of NF200-IR somata was significantly larger in subjects with schizophrenia than in controls. These results indicate that this neuronal subpopulation does not contribute to the smaller average size of neuronal somata in layer III of prefrontal cortical area 9 in schizophrenia or MDD. In addition, the enlarged somal size in schizophrenia as compared to controls suggests that NF200 neurons may contribute differentially to unique cognitive disturbances present in schizophrenia and not in MDD subjects.

Indexed as

AdultAgedAged, 80 and overCell CountFemaleHumansImmunohistochemistryMajor Depressive DisorderMaleMiddle AgedNeurofilament ProteinsNeuronsPrefrontal CortexPyramidal CellsSchizophreniaNeurofilament Proteins

Identifiers

PMID15949649
PMCPMC3146062
OpenAlexW2156383665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.